Drug
Vipadenant clinical trials
Also written BIIB014.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How studies write it
Studies that test it under each name
Development codes
- BIIB014
- 3
Studies by the year they started
4 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2009 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses vipadenant is read from its arms, and is right about nine times in ten.
Testing it · 5
- BIIB014 Effects on the Pharmacokinetics (PK) of Rosiglitazone, Warfarin, and MidazolamCompletedPhase 1BiogenNCT01017666Written as BIIB014
- BIIB014 Phase 2a MonotherapyWithdrawnPhase 2BiogenNCT00451815Written as active drug (BIIB014) at 10, 30, 100, or 300 mg once daily.
- BIIB014 Cardiovascular Monitoring StudyCompletedPhase 1BiogenNCT01035515Written as BIIB014 50mg
- Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's DiseaseCompletedPhase 2BiogenNCT00438607Written as BIIB014
- Using PET Scans to Study Brain Receptor Occupancy of BIIB014 in Healthy Male VolunteersCompletedPhase 1BiogenNCT00531193Written as BIIB014
Codes
What other systems call vipadenant · ClinicalTrials.gg INT005572
- MeSH (NLM) C5472743-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amineConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) LDR3USH1NJVIPADENANTConfirmed FDA, NLM, Wikidata
- Wikidata Q27089145vipadenantConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152892VipadenantOne source FDA
- DrugBank DB06625One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C547274 | 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | LDR3USH1NJ | VIPADENANT | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27089145 | vipadenant | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152892 | Vipadenant | One source FDA |
| DrugBank | DB06625 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.